MPE-282 | Interleukin Related interleukin-related.com

Product Name :
MPE-282

Search keywords :
CD36

drugId :
null

Target Vo:
Platelet glycoprotein 4

Target Vo Short Name :
CD36

Moa_Name:
Platelet glycoprotein 4 modulators

First Approval Country :

First Approval Date Filter:
null

Origin Company_Name :
Mperia Therapeutics Inc

Active Company_Name :
Mperia Therapeutics Inc

Active Indication_Name:
Metabolic Dysfunction-Associated Steatotic Liver Disease

In Active Indication_Name:

Termination Status :

China Termination Status :

Highest Status:
Preclinical

China Highest Status:

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
Phospho-STAT1 (Ser727) Rabbit mAb web
Odesivimab Anti-infection
p38 Antibody: p38 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 41 kDa, targeting to p38. It can be used for WB,IP assays with tag free, in the background of Human.

Author: Interleukin Related

Related Posts